It has been confirmed that drug therapy plays a role in remodeling the tumor immune microenvironment, such as decreased density of CD8+ cells and increased density of FoxP3+ cells and B cells (CD20+) in PTs after NAC, but PD-L1 expression did not change (338). The gene discussed is CD274; the disease is neoplasm.